Polymorphisms of apolipoprotein E gene and cognitive functions of postmenopausal women, measured by battery of computer tests - Central Nervous System Vital Signs

Neuroendocrinology Letters

Volumn 33, Issue 4, 2012, Pages 385-392

  Bojar, Iwona ^a   Wójcik Fatla, Angelina ^a   Owoc, Alfred ^b   Lewiński, Andrzej ^c  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b College of Public Health   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Apolipoprotein E gene; Cognitive functions; Menopause

Indexed keywords

FOLLITROPIN;

ADULT; AGED; APOLIPOPROTEIN E GENE; ARTICLE; ATTENTION; CENTRAL NERVOUS SYSTEM; COGNITION; DNA ISOLATION; EXECUTIVE FUNCTION; FEMALE; GENE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MONTREAL SCALE OF COGNITIVE FUNCTION ASSESSMENT; POSTMENOPAUSE; PSYCHOLOGIC TEST; PSYCHOMOTOR PERFORMANCE; RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM; VERBAL MEMORY; VISUAL MEMORY; VITAL SIGN;

EID: 84868383385     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, et al. (2008). Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet. 83: 623-632.
2. Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E, Atherosclerosis Risk in Communities (ARIC) Study Investigators (2005). APOE genotype and cognitive decline in a middle-aged cohort. Neurology 64: 268-276.
3. Blennow K, deLeon MJ, Zetterberg H (2006). Alzheimer's disease. Lancet 368: 387-403. (Pubitemid 44108123)
4. Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L (2004). APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology 63: 816-821. (Pubitemid 39297640)
5. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics 7: 180-184. (Pubitemid 24174658)
6. De Stefano N, Bartolozzi ML, Nacmias B (2004). Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. Arch Neurol. 61: 536-540. (Pubitemid 38923743)
7. Drzezga A, Grimmer T, Henriksen G, Mühlau M, Perneczky R, Miederer I, et al. (2009). Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology 72: 1487-1494.
8. Farrer L, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeaux R, et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278: 1349-1356. (Pubitemid 27449696)
9. Ghebremedhin E, Del Tredici K, Vuksic M (2006). Relationship of apolipoprotein E and age at onset to Parkinson disease neuropathology. J. Neuropathol Exp Neurol. 65: 116-123.
10. Gromadzka G, Barańska-Gieruszczak M, Ciesielska A, Sarzyńska-Dlugosz I, Członkowska A, et al. (2005). APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke In men and women. Cerebrovasc Dis. 20: 291-298. (Pubitemid 41551977)
11. Gromadzka G, Barańska-Gieruszczak M, Sarzyńska- Długosz I, Ciesielska A, Czlonkowska A, et al. (2007). The APOE polimorphism and 1-year outcome in ischemic stroke: genotype-gender interactions. Acta Neurol Scand. 116: 392-398. (Pubitemid 350045495)
12. Gualtieri CT, Johnson LG (2006). Reliability and validity of computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol. 21: 623-643. (Pubitemid 44754740)
13. Kalaria RN (2000). The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21: 321-330.
14. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A (2000). Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 54: 2072-2077. (Pubitemid 30397204)
15. Kowalska A (2009). Genetyka zespołow otȩpiennych. Czȩść 3: podłoże molekularne wieloczynnikowego dziedziczenia postaci sporadycznej choroby Alzheimera. [(The genetics of dementias, Part 3: A molecular basis for the multifactorial inheritance of sporadic Alzheimer's disease.) (In Polish with English abstract)] Postȩpy Hig Med. Dosw. 63: 577-582.
16. Lam TT, Leranth C (2003). Gonadal hormones act extrinsic to the hippocampus to influence the density of hippocampal astroglial processes. Neuroscience 116: 491-498. (Pubitemid 36139919)
17. Magierska J, Magierski R, Sobow T, Kloszewska I. The Polish adaptation of the Montreal Cognitive Assessment (MoCA) and preliminary results of its clinical utility in the screening for cognitive impairment. Presented at ICAD Conference Poster 2008, Chicago.
18. Manly JJ, Merchant CA, Jacobs DM (2000). Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 54: 833-837. (Pubitemid 30111338)
19. Mayeux R (2003). Epidemiology of neurodegeneration. Ann Rev Neurosci. 26: 81-104.
20. McAsey ME, Cady C, Jackson LM (2006). Time course of response to estradiol replacement in ovariectomized mice: brain apolipoprotein E and synaptophysin transiently increase and glial fibrillary acidic protein is suppressed. Exp Neurol. 197: 197-205. (Pubitemid 41817233)
21. McEwen B (2002). Estrogen actions throughout the brain. Recent Prog Horm Res. 57: 357-384.
22. Mendel T, Gromadzka G (2010). Polimorfizm genu apolipoproteiny E (APOE) a ryzyko i rokowanie w krwotokach mózgowych spowodowanych przez mózgowa̧ angiopatiȩ amyloidowa̧. [(Apolipoprotein E (APOE) gene polymorphism and risk and prognosis in cerebral amyloid angiopathy-related haemorrhage.) (In Polish with English abstract)] Neurol Neurochir Pol. 44: 591-597.
23. Morris JC, Rose CM, Xiong Ch, Fagan AM, Goate AM, Holtzman DM, et al. (2010). APOE predicts Aβ but not Tau Alzheimer's pathology in cognitively normal aging. Ann Neurol. 67: 122-131.
24. Nathan BP, Barsukova AG, Shen F (2004). Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology 145: 3065-3073. (Pubitemid 38829971)
25. Nyholt DR, Yu CE, Visscher PM (2009). On Jim Watson's APOE status: genetic information is hard to hide. Eur J Hum Genet. 17: 147-149.
26. Palmer K, Fratiglioni L, Winblad B (2003). What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment. Acta Neurol Scand Suppl. 179: 14-20.
27. Petanceska SS, Nagy V, Frail D (2000). Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology 54: 2212-2217. (Pubitemid 30416268)
28. Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ (2002). Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58: 1629-1634. (Pubitemid 34602893)
29. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN (1996). Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol. 148: 2083-2095.
30. Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, et al. (2004). Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 63: 651-657. (Pubitemid 39100820)
31. Sherwin BB (1998). Estrogen and cognitive functioning in women. Proc Soc Exp Biol Med. 217: 17-22.
32. Small GW (2002). Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease. Adv Drug Deliv Rev. 54: 1561-1566.
33. Talbot C, Lendon C, Craddock N Shears S, Morris JC, Goate A (1994). Protection against Alzheimer's disease with apoE ε2. Lancet. 343: 1432-1433. (Pubitemid 24167530)
34. Trembath D, Ervin JF, Broom L, Szymanski M, Welsh-Bohmer K, Pieper C, et al. (2007). The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype. Acta Neuropathol. 113: 23-31. (Pubitemid 44782926)
35. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. (2004). Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 256: 240-246. (Pubitemid 39222993)
36. Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, et al. (2006). Increased brain activation during working memory in cognitively intact adults with the APOE ε4 allele. Am J Psychiatry 163: 1603-1610. (Pubitemid 44465762)
37. Yang YG, Kim JY, Park SJ, Kim SW, Jeon OH, Kim DS (2007). Apolipoprotein E genotyping by multiplex tetra-primer amplification refractory mutation system PCR in single reaction tube. J Biotech. 131: 106-110. (Pubitemid 47187504)